Sutro Biopharma | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Deals

30 November 2023

AbbVie banishes the ghost of Stemcentrx

Yet another ADC deal sees AbbVie buy ImmunoGen, ending a 40-year rollercoaster ride with a 100% overnight premium.

Subscribe to Sutro Biopharma